Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2015

01-08-2015 | Original Article

Correlation Between Timed Barium Esophagogram and Esophageal Transit Scintigraphy Results in Achalasia

Authors: Yoo Mi Park, Han Ho Jeon, Jae Jun Park, Jie-Hyun Kim, Young Hoon Youn, Hyojin Park

Published in: Digestive Diseases and Sciences | Issue 8/2015

Login to get access

Abstract

Background

Timed barium esophagogram (TBE) and esophageal transit scintigraphy (ETS) have been adopted as useful ways to evaluate achalasia patients. TBE has merit as a simple, non-invasive, and convenient method.

Aims

The study sought to compare the results of these two tests and verify their usefulness in evaluating treatment response. In addition, we assessed whether TBE could effectively replace ETS through correlation analysis.

Methods

The medical records of 50 achalasia patients treated between September 2011 and June 2014 were reviewed retrospectively. The height and width of the barium column at 1, 2, and 5 min were measured by TBE. Half-life (T 1/2, min) and R 30 (percentage of remaining radioactivity 30 s after radioisotope ingestion) were measured by ETS. Both tests were performed before and after treatment, and the tests were carried out 1 and 2 days after procedures. And we analyzed the correlation between the parameters from the two tests.

Results

The parameters of TBE and ETS were improved after treatment (p < 0.05). Before treatment, the height and width results at 5 min from TBE positively correlated with the T 1/2 parameter from ETS (correlation coefficients of 0.59 and 0.75, respectively). After treatment, the correlation coefficients between the 5-min height and width of the barium column by TBE and T 1/2 by ETS were 0.55 and 0.46, respectively.

Conclusions

Both TBE and ETS are useful modalities in assessing esophageal emptying and response to achalasia treatment. TBE and ETS results have a statistically significant correlation both pre- and post-treatment. We suggest that TBE could effectively replace ETS for the assessment of achalasia.
Literature
2.
go back to reference Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100:1404–1414.PubMedCrossRef Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100:1404–1414.PubMedCrossRef
3.
go back to reference Kostic SV, Rice TW, Baker ME, et al. Timed barium esophagogram: a simple physiologic assessment for achalasia. J Thorac Cardiovasc Surg. 2000;120:935–943.PubMedCrossRef Kostic SV, Rice TW, Baker ME, et al. Timed barium esophagogram: a simple physiologic assessment for achalasia. J Thorac Cardiovasc Surg. 2000;120:935–943.PubMedCrossRef
4.
go back to reference Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011;8:311–319.PubMedCrossRef Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011;8:311–319.PubMedCrossRef
5.
go back to reference Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–174.PubMedCrossRef Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–174.PubMedCrossRef
6.
go back to reference Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8:30–35.PubMedCrossRef Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8:30–35.PubMedCrossRef
7.
go back to reference Yamashita H, Ashida K, Fukuchi T, et al. Predictive factors associated with the success of pneumatic dilatation in Japanese patients with primary achalasia: a study using high-resolution manometry. Digestion. 2013;87:23–28.PubMedCrossRef Yamashita H, Ashida K, Fukuchi T, et al. Predictive factors associated with the success of pneumatic dilatation in Japanese patients with primary achalasia: a study using high-resolution manometry. Digestion. 2013;87:23–28.PubMedCrossRef
8.
go back to reference Vaezi MF, Baker ME, Achkar E, et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50:765–770.PubMedCentralPubMedCrossRef Vaezi MF, Baker ME, Achkar E, et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50:765–770.PubMedCentralPubMedCrossRef
9.
go back to reference Andersson M, Lundell L, Kostic S, et al. Evaluation of the response to treatment in patients with idiopathic achalasia by the timed barium esophagogram: results from a randomized clinical trial. Dis Esophagus. 2009;22:264–273.PubMedCrossRef Andersson M, Lundell L, Kostic S, et al. Evaluation of the response to treatment in patients with idiopathic achalasia by the timed barium esophagogram: results from a randomized clinical trial. Dis Esophagus. 2009;22:264–273.PubMedCrossRef
10.
go back to reference Prasek J, Hep A, Dolina J, et al. Dynamic esophageal scintigraphy in patients with achalasia. Nucl Med Rev Cent East Eur. 2000;3:57–60.PubMed Prasek J, Hep A, Dolina J, et al. Dynamic esophageal scintigraphy in patients with achalasia. Nucl Med Rev Cent East Eur. 2000;3:57–60.PubMed
11.
go back to reference Shen YY, Shiau YC, Sun SS, et al. Using radionuclide esophageal emptying test to evaluate pneumatic dilatation effects for achalasia. Hepato-Gastroenterology. 2001;48:1061–1063.PubMed Shen YY, Shiau YC, Sun SS, et al. Using radionuclide esophageal emptying test to evaluate pneumatic dilatation effects for achalasia. Hepato-Gastroenterology. 2001;48:1061–1063.PubMed
12.
go back to reference Jeon HH, Youn YH, Rhee K, et al. For patients with primary achalasia the clinical success of pneumatic balloon dilatation can be predicted from the residual fraction of radionuclide during esophageal transit scintigraphy. Dig Dis Sci. 2014;59:375–382.PubMedCrossRef Jeon HH, Youn YH, Rhee K, et al. For patients with primary achalasia the clinical success of pneumatic balloon dilatation can be predicted from the residual fraction of radionuclide during esophageal transit scintigraphy. Dig Dis Sci. 2014;59:375–382.PubMedCrossRef
13.
go back to reference Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265–271.PubMedCrossRef Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265–271.PubMedCrossRef
14.
go back to reference Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol. 2007;293:G878–G885.PubMedCrossRef Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol. 2007;293:G878–G885.PubMedCrossRef
15.
go back to reference Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–1738.PubMed Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–1738.PubMed
16.
go back to reference Birgisson S, Richter JE. Achalasia: What’s new in diagnosis and treatment? Dig Dis. 1997;15:1–27.PubMedCrossRef Birgisson S, Richter JE. Achalasia: What’s new in diagnosis and treatment? Dig Dis. 1997;15:1–27.PubMedCrossRef
17.
go back to reference Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol. 1998;27:21–35.PubMedCrossRef Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol. 1998;27:21–35.PubMedCrossRef
18.
19.
go back to reference Kahrilas PJ, Clouse RE, Hogan WJ. American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology. 1994;107:1865–1884.PubMedCrossRef Kahrilas PJ, Clouse RE, Hogan WJ. American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology. 1994;107:1865–1884.PubMedCrossRef
20.
go back to reference Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135:1526–1533.PubMedCentralPubMedCrossRef Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135:1526–1533.PubMedCentralPubMedCrossRef
21.
go back to reference Cho YK, Lipowska AM, Nicodeme F, et al. Assessing bolus retention in achalasia using high-resolution manometry with impedance: a comparator study with timed barium esophagram. Am J Gastroenterol. 2014;109:829–835.PubMedCentralPubMedCrossRef Cho YK, Lipowska AM, Nicodeme F, et al. Assessing bolus retention in achalasia using high-resolution manometry with impedance: a comparator study with timed barium esophagram. Am J Gastroenterol. 2014;109:829–835.PubMedCentralPubMedCrossRef
22.
go back to reference Chung JJ, Park HJ, Yu JS, et al. A comparison of esophagography and esophageal transit scintigraphy in the evaluation of usefulness of endoscopic pneumatic dilatation in achalasia. Acta Radiol. 2008;49:498–505.PubMedCrossRef Chung JJ, Park HJ, Yu JS, et al. A comparison of esophagography and esophageal transit scintigraphy in the evaluation of usefulness of endoscopic pneumatic dilatation in achalasia. Acta Radiol. 2008;49:498–505.PubMedCrossRef
23.
go back to reference Moon JT, Jung IS, Kim YS, et al. Correlation between clinical symptoms and radiologic findings before and after pneumatic balloon dilatation for achalasia. Korean J Gastroenterol. 2008;52:16–20.PubMed Moon JT, Jung IS, Kim YS, et al. Correlation between clinical symptoms and radiologic findings before and after pneumatic balloon dilatation for achalasia. Korean J Gastroenterol. 2008;52:16–20.PubMed
24.
go back to reference Rhee K, Jeon H, Kim JH, et al. An evidence of esophageal decompensation in patients with achalasia in the view of its subtype: a retrospective study. J Neurogastroenterol Motil. 2013;19:319–323.PubMedCentralPubMedCrossRef Rhee K, Jeon H, Kim JH, et al. An evidence of esophageal decompensation in patients with achalasia in the view of its subtype: a retrospective study. J Neurogastroenterol Motil. 2013;19:319–323.PubMedCentralPubMedCrossRef
25.
go back to reference Lee JY, Kim N, Kim SE, et al. Clinical characteristics and treatment outcomes of 3 subtypes of achalasia according to the chicago classification in a tertiary institute in Korea. J Neurogastroenterol Motil. 2013;19:485–494.PubMedCentralPubMedCrossRef Lee JY, Kim N, Kim SE, et al. Clinical characteristics and treatment outcomes of 3 subtypes of achalasia according to the chicago classification in a tertiary institute in Korea. J Neurogastroenterol Motil. 2013;19:485–494.PubMedCentralPubMedCrossRef
26.
go back to reference Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144:718–725. quiz e713-714.PubMedCrossRef Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144:718–725. quiz e713-714.PubMedCrossRef
27.
go back to reference Baker ME. Is barium column surface area a better predictor of primary achalasia disease severity than barium column height? Nat Clin Pract Gastroenterol Hepatol. 2007;4:308–309.PubMedCrossRef Baker ME. Is barium column surface area a better predictor of primary achalasia disease severity than barium column height? Nat Clin Pract Gastroenterol Hepatol. 2007;4:308–309.PubMedCrossRef
28.
go back to reference Zanoni A, Rice TW, Lopez R, et al. Timed barium esophagram in achalasia types. Dis Esophagus. 2015;28:336–344.PubMedCrossRef Zanoni A, Rice TW, Lopez R, et al. Timed barium esophagram in achalasia types. Dis Esophagus. 2015;28:336–344.PubMedCrossRef
29.
go back to reference Johnston BT, Collins BJ, Collins JS, et al. Perendoscopic pneumatic dilatation in achalasia: assessment of outcome using esophageal scintigraphy. Dysphagia. 1992;7:201–204.PubMedCrossRef Johnston BT, Collins BJ, Collins JS, et al. Perendoscopic pneumatic dilatation in achalasia: assessment of outcome using esophageal scintigraphy. Dysphagia. 1992;7:201–204.PubMedCrossRef
30.
go back to reference Chawda SJ, Watura R, Adams H, et al. A comparison of barium swallow and erect esophageal transit scintigraphy following balloon dilatation for achalasia. Dis Esophagus. 1998;11:181–187. discussion 187–188.PubMed Chawda SJ, Watura R, Adams H, et al. A comparison of barium swallow and erect esophageal transit scintigraphy following balloon dilatation for achalasia. Dis Esophagus. 1998;11:181–187. discussion 187–188.PubMed
Metadata
Title
Correlation Between Timed Barium Esophagogram and Esophageal Transit Scintigraphy Results in Achalasia
Authors
Yoo Mi Park
Han Ho Jeon
Jae Jun Park
Jie-Hyun Kim
Young Hoon Youn
Hyojin Park
Publication date
01-08-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3659-z

Other articles of this Issue 8/2015

Digestive Diseases and Sciences 8/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine